Albemarle Corporation is an American specialty chemicals manufacturing company based in Charlotte, North Carolina. It serves several different industries including Agriculture/Food, Automotive/EV, Aviation/Aerospace, Building/Construction, Conventional Energy, Electronics, Grid Storage, and Industrial Processes. The company reported over $5.4 Billion in revenue in 2024.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| ALB | ALBEMARLE CORP | 2025-10-16 22:20:47 | 93.35 | -1.94 | -2.04 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALB | 0000915913 | ALBEMARLE CORP | US0126531013 | HDBLS2Q6GV1LSKQPBS54 | 541692118 | NYSE | 2821 | Plastic Materials, Synth Resins & Nonvulcan Elastomers | 1231 | VA | 4250 CONGRESS STREET | CHARLOTTE | NC | 28209 | UNITED STATES | US | 980-299-5700 | 4250 CONGRESS STREET, CHARLOTTE, NC, 28209 | 4250 CONGRESS STREET, CHARLOTTE, NC, 28209 | — | Chemical industry | 1994 | Kent Masters | 8,300 | http://albemarle.com | 11,200,000,000 | 117,669,000 | 117,682,932 | Albemarle Corporation is an American specialty chemicals manufacturing company based in Charlotte, North Carolina. It serves several different industries including Agriculture/Food, Automotive/EV, Aviation/Aerospace, Building/Construction, Conventional Energy, Electronics, Grid Storage, and Industrial Processes. The company reported over $5.4 Billion in revenue in 2024. | 2025-10-10 19:47:40 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 11,200,000,000 | -15,000,000,000 | -57.2519 | 117,573,461 | 170,512 | 0.1452 |
| 2023 | 26,200,000,000 | 1,700,000,000 | 6.9388 | 117,402,949 | 204,972 | 0.1749 |
| 2022 | 24,500,000,000 | 0 | 0 | 117,197,977 | 0 | 0 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Netha N. Johnson | Chief Operations Officer, Executive Vice President | 2024 | 636,571 | 0 | 1,576,174 | 487,274 | 115,065 | 3,315,087 |
| Eric W. Norris | Chief Commercial Officer, Executive Vice President | 2024 | 640,181 | 0 | 1,576,174 | 573,730 | 144,051 | 3,434,139 |
| J. Kent Masters | Chairman, Chief Executive Officer | 2024 | 1,400,000 | 0 | 7,880,872 | 2,201,850 | 385,761 | 14,368,498 |
| Neal R. Sheorey | Chief Financial Officer, Executive Vice President | 2024 | 600,000 | 0 | 1,576,174 | 503,280 | 283,879 | 3,463,336 |
| Kristin M. Coleman | Corporate Secretary, Executive Vice President, General Counsel | 2024 | 645,779 | 0 | 866,877 | 0 | 2,959,135 | 4,746,800 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 8,300 |
| 2023 | 9,000 |
| 2022 | 7,400 |
| Fiscal Year | 2024 | 2023 | 2021 |
|---|---|---|---|
| Revenue | 5,377,526,000 | 9,617,203,000 | 3,327,957,000 |
| Cost Of Revenue | 5,314,987,000 | 8,431,294,000 | 2,329,986,000 |
| Gross Profit | 62,539,000 | 1,185,909,000 | 997,971,000 |
| Research And Development Expenses | 86,720,000 | 85,725,000 | 54,026,000 |
| General And Administrative Expenses | 618,048,000 | 919,493,000 | 441,482,000 |
| Operating Expenses | — | — | — |
| Operating Income | -1,776,545,000 | 251,881,000 | 798,434,000 |
| Net Income | -1,179,449,000 | 1,573,476,000 | 123,672,000 |
| Earnings Per Share Basic | -11.2 | 13.41 | 1.07 |
| Earnings Per Share Diluted | -11.2 | 13.36 | 1.06 |
| Weighted Average Shares Outstanding Basic | 117,516,000 | 117,317,000 | 115,841,000 |
| Weighted Average Shares Outstanding Diluted | 117,516,000 | 117,766,000 | 116,536,000 |
| Fiscal Year | 2024 | 2023 | 2021 |
|---|---|---|---|
| Cash And Cash Equivalents | 1,192,230,000 | 889,900,000 | 439,272,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 742,201,000 | 1,213,160,000 | 556,922,000 |
| Inventories | 1,502,531,000 | 2,161,287,000 | 812,920,000 |
| Non Trade Receivables | 84,975,000 | 112,953,000 | 30,426,000 |
| Other Assets Current | 166,916,000 | 443,475,000 | 132,683,000 |
| Total Assets Current | 3,842,262,000 | 5,216,919,000 | 2,007,981,000 |
| Marketable Securities Non Current | 60,626,000 | 207,028,000 | 37,187,000 |
| Property Plant And Equipment | — | — | 5,909,616,000 |
| Other Assets Non Current | 504,711,000 | 297,087,000 | 252,239,000 |
| Total Assets Non Current | 10,057,955,000 | 10,350,851,000 | 6,502,834,000 |
| Total Assets | 16,609,649,000 | 18,270,652,000 | 10,974,118,000 |
| Accounts Payable | 793,455,000 | 1,537,859,000 | 647,986,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 398,023,000 | 625,761,000 | 389,920,000 |
| Other Liabilities Current | 467,997,000 | 544,835,000 | 763,293,000 |
| Total Liabilities Current | 1,966,464,000 | 3,560,462,000 | 1,874,335,000 |
| Long Term Debt | 3,516,165,000 | 4,166,763,000 | 2,394,239,000 |
| Other Liabilities Non Current | 819,204,000 | 769,100,000 | 663,698,000 |
| Total Liabilities Non Current | 1,727,181,000 | 1,267,271,000 | 739,599,000 |
| Total Liabilities | 2,117,703,000 | 2,041,202,000 | 949,220,000 |
| Common Stock | 1,176,000 | 1,174,000 | 1,170,000 |
| Retained Earnings | 5,481,692,000 | 6,987,015,000 | 3,096,539,000 |
| Accumulated Other Comprehensive Income | -742,062,000 | -528,526,000 | -392,450,000 |
| Total Shareholders Equity | 9,961,517,000 | 9,412,180,000 | 5,625,266,000 |
| Fiscal Year | 2024 | 2023 | 2021 |
|---|---|---|---|
| Depreciation And Amortization | 588,638,000 | 429,944,000 | 254,000,000 |
| Share Based Compensation Expense | 32,141,000 | 36,545,000 | 20,120,000 |
| Other Non Cash Income Expense | 107,104,000 | 114,572,000 | -53,521,000 |
| Change In Accounts Receivable | -555,218,000 | 350,655,000 | 49,295,000 |
| Change In Inventories | -1,560,450,000 | 962,924,000 | 127,401,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -244,987,000 | 171,870,000 | -17,411,000 |
| Change In Accounts Payable | -462,839,000 | -315,220,000 | 143,939,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 702,068,000 | 1,325,321,000 | 344,257,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 1,685,790,000 | 2,149,281,000 | 953,667,000 |
| Acquisition Of Business | — | — | 820,000,000 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -1,574,438,000 | -2,781,160,000 | -666,590,000 |
| Tax Withholding For Share Based Compensation | 11,891,000 | 27,468,000 | 8,140,000 |
| Payments Of Dividends | 244,590,000 | 240,224,000 | 278,521,000 |
| Issuance Of Common Stock | — | 0 | 1,453,888,000 |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 112,439,000 | 356,047,000 | 0 |
| Repayment Of Long Term Debt | 112,439,000 | 28,862,000 | 1,173,823,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 1,241,735,000 | 623,911,000 | 50,212,000 |
| Change In Cash | 302,330,000 | -609,242,000 | -307,452,000 |
| Cash At End Of Period | 1,192,230,000 | 889,900,000 | 439,272,000 |
| Income Taxes Paid | 262,845,000 | 319,391,000 | 130,840,000 |
| Interest Paid | 150,689,000 | 101,978,000 | 27,734,000 |
| Fiscal Year | 2024 | 2023 | 2021 |
|---|---|---|---|
| Earnings Per Share | -11.2 | 13.41 | 1.07 |
| Price To Earnings Ratio | -7.6857 | 10.774 | 218.4766 |
| Earnings Growth Rate | -183.5198 | 1,153.271 | -69.6884 |
| Price Earnings To Growth Ratio | 0.0419 | 0.0093 | -3.1351 |
| Book Value Per Share | 123.3189 | 138.3384 | 86.5402 |
| Price To Book Ratio | 0.698 | 1.0444 | 2.7013 |
| Ebitda | -327,966,000 | 2,322,811,000 | 508,512,000 |
| Enterprise Value | 12,837,735,280 | 20,852,584,160 | 29,425,037,570 |
| Dividend Yield | 0.0242 | 0.0142 | 0.0103 |
| Dividend Payout Ratio | -0.2074 | 0.1527 | 2.2521 |
| Debt To Equity Ratio | 0.3929 | 0.5092 | 0.4949 |
| Capital Expenditures | — | — | 808,991,000 |
| Free Cash Flow | — | — | -464,734,000 |
| Return On Equity | -0.1184 | 0.1672 | 0.022 |
| One Year Beta | 1.8226 | 1.8018 | 1.5981 |
| Three Year Beta | 1.5147 | 1.4849 | 1.2998 |
| Five Year Beta | 1.3694 | 1.3549 | 1.2505 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Krupa Ander C. | General Counsel & Sec | 2025-10-09 | 116 | D | 11,655 |
| Krupa Ander C. | General Counsel & Sec | 2025-08-06 | 7,430 | A | 11,771 |
| MINOR GLENDA J | Director | 2025-07-01 | 37 | A | 5,893 |
| MINOR GLENDA J | Director | 2025-07-01 | 2,725 | A | 4,313 |
| Van Deursen Holly | Director | 2025-07-01 | 2,725 | A | 8,692 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| David A Perdue , Jr | Senator | 2021-05-02 | Sale (Partial) | 2020-02-19 | Joint | $1,001 - $15,000 |
| David A Perdue , Jr | Senator | 2021-05-02 | Sale (Full) | 2020-04-14 | Joint | $50,001 - $100,000 |
| David A Perdue , Jr | Senator | 2020-05-08 | Sale (Full) | 2020-04-14 | Joint | $50,001 - $100,000 |
| David A Perdue , Jr | Senator | 2020-03-03 | Sale (Partial) | 2020-02-19 | Joint | $1,001 - $15,000 |
| David A Perdue , Jr | Senator | 2020-02-03 | Purchase | 2020-01-06 | Joint | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Jefferson Shreve | 2025-06-22 | IN06 | Sale | 2025-05-12 | — | $15,001 - $50,000 |
| Jefferson Shreve | 2025-05-08 | IN06 | Purchase | 2025-04-07 | — | $15,001 - $50,000 |
| Julie Johnson | 2025-03-12 | TX32 | Sale | 2025-02-12 | Joint | $1,001 - $15,000 |
| Jefferson Shreve | 2025-03-09 | IN06 | Sale | 2025-02-24 | — | $15,001 - $50,000 |
| Richard W. Allen | 2024-01-11 | GA12 | Sale | 2023-12-21 | Spouse | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| GREENWOOD CAPITAL ASSOCIATES LLC | 2025-09-30 | 4,066,648 | 50,156 | 81.08 |
| Portman Square Capital LLP | 2025-09-30 | 1,482,223 | 18,281 | 81.08 |
| Portman Square Capital LLP | 2025-09-30 | 20,756,480 | 256,000 | 81.08 |
| MEYER HANDELMAN CO | 2025-09-30 | 397,292 | 4,900 | 81.08 |
| HALBERT HARGROVE GLOBAL ADVISORS, LLC | 2025-09-30 | 1,703 | 21 | 81.0952 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Mid Cap Fund | CFMCX | 19,178 | 1,628,595.76 | 0.1634 |
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Mid Cap Select Fund | CFMSX | 106,341 | 9,030,477.72 | 0.3479 |
| ETF Series Solutions | 2025-07-31 | Aptus Large Cap Enhanced Yield ETF | DUBS | 351 | 23,815.35 | 0.01 |
| Pacer Funds Trust | 2025-07-31 | Pacer Trendpilot US Large Cap ETF | PTLC | 7,276 | 493,676.6 | 0.0148 |
| Pacer Funds Trust | 2025-07-31 | Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF | QDPL | 2,133 | 144,724.05 | 0.0133 |